Regulatory T cells (Tregs) are a barrier to anti-tumor immunity. Neuropilin-1 (Nrp1) is required to maintain intratumoral Treg stability and function but is dispensable for peripheral immune tolerance. Treg-restricted Nrp1 deletion results in profound tumor resistance due to Treg functional fragility. Thus, identifying the basis for Nrp1 dependency and the key drivers of Treg fragility could help to improve immunotherapy for human cancer. We show that a high percentage of intratumoral NRP1+ Tregs correlates with poor prognosis in melanoma and head and neck squamous cell carcinoma. Using a mouse model of melanoma where Nrp1-deficient (Nrp1-/-) and wild-type (Nrp1+/+) Tregs can be assessed in a competitive environment, we find that a high proportion of intratumoral Nrp1-/- Tregs produce interferon-γ (IFNγ), which drives the fragility of surrounding wild-type Tregs, boosts anti-tumor immunity, and facilitates tumor clearance. We also show that IFNγ-induced Treg fragility is required for response to anti-PD1, suggesting that cancer therapies promoting Treg fragility may be efficacious.
Pubmed ID: 28552348 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Stat1, phospho (Tyr701)
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets Human/Mouse HIF-1 alpha, aa 575-826
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis isotype control targets Unknown Specificity
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets Akt, phospho (Ser473)
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD119 (IFN gamma Receptor 1)
View all literature mentionsThis monoclonal targets Stat4, phospho (Tyr693)
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets CD8b
View all literature mentionsJava toolset for working with next generation sequencing data in the BAM format.
View all literature mentionsTHIS RESOURCE IS NO LONGER IN SERVICE, documented on February 1st, 2022. Software application for genetic analysis of classical biometric traits like blood pressure or height that are caused by a combination of polygenic inheritance and complex environmental forces. (entry from Genetic Analysis Software)
View all literature mentionsSoftware package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.
View all literature mentionsMus musculus with name B6.129S7-Ifngtm1Ts/J from IMSR.
View all literature mentionsMus musculus with name B6.129S7-Ifngr1tm1Agt/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6N-Ifngr1tm1.1Rds/J from IMSR.
View all literature mentionsThis monoclonal targets Human/Mouse HIF-1 alpha, aa 575-826
View all literature mentionsThis isotype control targets Unknown Specificity
View all literature mentionsThis monoclonal targets Human/Mouse HIF-1 alpha, aa 575-826
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis isotype control targets Unknown Specificity
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD119 (IFN gamma Receptor 1)
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD119 (IFN gamma Receptor 1)
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets Stat4, phospho (Tyr693)
View all literature mentionsThis monoclonal targets Stat1, phospho (Tyr701)
View all literature mentionsThis monoclonal targets Stat4, phospho (Tyr693)
View all literature mentionsThis monoclonal targets Stat1, phospho (Tyr701)
View all literature mentionsThis monoclonal targets Akt, phospho (Ser473)
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets Akt, phospho (Ser473)
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD4
View all literature mentions